PREIS, J. R. (2023). THE METABOLISM AND THE MICROENVIRONMENT MODULATE DRUG VULNERABILITIES IN MELANOMA: STUDIES WITH ADVANCED CELL CULTURE MODELS AND A COMPOUND SCREEN [Doctoral thesis, Unilu - University of Luxembourg]. ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/58772 |
RANDIC, T., MAGNI, S., PHILIPPIDOU, D., Margue, C., GRZYB, K., PREIS, J. R., WROBLEWSKA, J. P., NAZAROV, P., MITTELBRONN, M., FRAUENKNECHT, K., SKUPIN, A., & KREIS, S. (25 July 2023). Single-cell transcriptomics of NRAS-mutated melanoma transitioning to drug resistance reveals P2RX7 as an indicator of early drug response. Cell Reports, 42 (7), 112696. doi:10.1016/j.celrep.2023.112696 Peer Reviewed verified by ORBi |
Reigstad, A., Herdlevær, C. F., Rigg, E., Hoang, T., Bjørnstad, O. V., Aasen, S. N., Preis, J. R., Haan, C., Sundstrøm, T., & Thorsen, F. (2022). CCT196969 effectively inhibits growth and survival of melanoma brain metastasis cells. PLoS ONE. doi:10.1371/journal.pone.0273711 Peer Reviewed verified by ORBi |